As clinicians, you may be familiar with the International Organization for Standardization (ISO) standards that govern quality assurance for intraocular lenses (IOLs). These standards permit a variance between the labeled power and the actual measured power, commonly referred to as lens power tolerance.

According to these ISO guidelines, IOL manufacturers are allowed tolerances of up to ±0.4D for mid-range powers and as much as ±1.0D for higher powers. In practical terms, this implies that a lens labeled +19.5D may, in reality, be closer to a +20.0D lens, raising pertinent questions about the clinical significance of half power increments within this tolerance framework.

In contrast, Lenstec’s proprietary manufacturing processes exceed ISO standards by significantly reducing lens power tolerances to ±0.11D. This enhanced level of precision highlights our commitment to providing the most accurate IOLs in the global market, thereby contributing to improved clinical outcomes.

Our advanced technology incorporates smaller dioptric increments of 0.25D, in contrast to the industry-standard 0.5D. This innovation enables clinicians to achieve patient outcomes that more closely align with the intended target refraction, with greater accuracy and precision, all without necessitating alterations to established workflows or surgical procedures.

Lenstec’s IOLs set a new benchmark for accuracy within the intraocular lens and broader medical device industry, thereby enhancing patient outcomes with every lens implanted.